Clinical Trial Update: Molecular Assessment of Lymph Nodes in Patients With Resected (Stage I to IIIA) Non-small Cell Lung Cancer

View source ↗

Summary

This clinical trial update describes a study evaluating molecular assessment of lymph nodes in patients with resected stage I–IIIA non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Lung Cancer | Status: COMPLETED